Growers work to keep costs low. Cannabis is decriminalized in Virginia. M&A activity continues to slow. And injectable CBD products are recalled after FDA warnings.
"Essential" businesses navigate a new environment. The House includes cannabis banking in its COVID relief bill. And Q1 2020 earnings are announced.
We look at the uneven impact the pandemic has had on adult-use cannabis sales from state to state. Cultivators adapt to the new normal. And 2/3 of Pennsylvania residents favor adult-use legalization.
Cannabis industry leaders outline their shifts in marketing tactics since the pandemic hit. Wholesale cannabis prices waver after a February peak. Medical marijuana sales are up in Massachusetts. And the FTC sues a CBD company over cancer and COVID-19 claims.
Hound Lab gears up to manufacture a cannabis breathalyzer. Small marijuana businesses may soon get access to federal COVID-19 relief funds. Online marketing for cannabis becomes more important. And we break down legalization efforts in NY and NJ.
The spotlight this week is on presumptive Democratic presidential nominee Joe Biden and his stance on cannabis legalization. Retailers adjust to the tourism downturn. Canopy Growth scales back. And researchers outline how cannabis treats headaches and migraines.
We take look at the CARES Act for cannabis companies. March sales paint a new picture of the industry. iAnthus can't make its interest payments. A new study finds that cannabis may help ease symptoms of opioid withdrawal. And cannabusinesses give back to their communities.
Illinois shops in March sell almost $36 million of recreational products. Epidiolex is no longer a controlled substance. Senators push for cannabusinesses to gain access to federal loan programs. And companies opt for virtual 4/20 celebrations.